Review: could Amaryl cause Pancreatic Cancer?


Pancreatic cancer is found among people who take Amaryl, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Victoza, and have Type 2 diabetes mellitus . We study 22,456 people who have side effects while taking Amaryl from FDA and social media. Among them, 98 have Pancreatic cancer. Find out below who they are, when they have Pancreatic cancer and more.

You are not alone

Join a support group for people who take Amaryl and have Pancreatic cancer >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Amaryl has active ingredients of glimepiride. It is often used in diabetes. (latest outcomes from Amaryl 22,722 users)

Pancreatic Cancer

Pancreatic cancer has been reported by people with death, rashes, thrombocytopenia, malignant neoplasm progression, diarrhea (latest reports from 11,374 Pancreatic cancer patients).

On Aug, 26, 2016

22,456 people reported to have side effects when taking Amaryl.
Among them, 98 people (0.44%) have Pancreatic Cancer

Number of reports submitted per year:

Could Amaryl cause Pancreatic cancer?

Time on Amaryl when people have Pancreatic Cancer *:

  • < 1 month: 8.33 %
  • 1 - 6 months: 50.0 %
  • 6 - 12 months: 16.67 %
  • 1 - 2 years: 8.33 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 16.67 %

Gender of people who have Pancreatic Cancer when taking Amaryl *:

  • female: 36.08 %
  • male: 63.92 %

Age of people who have Pancreatic Cancer when taking Amaryl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.35 %
  • 40-49: 5.88 %
  • 50-59: 15.29 %
  • 60+: 76.47 %

Top conditions involved for these people *:

  • Type 2 Diabetes Mellitus (55 people)
  • Diabetes Mellitus (22 people)
  • Hypertension (19 people)
  • Hyperlipidaemia (10 people)
  • Gastrooesophageal Reflux Disease (5 people)

Top co-used drugs for these people *:

  • Victoza (19 people)
  • Januvia (16 people)
  • Actos (16 people)
  • Byetta (14 people)
  • Glucophage (12 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Pancreatic cancer when taking Amaryl?

Browse all side effects of Amaryl

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Pancreatic cancer

Pancreatic cancer

Could your condition cause Pancreatic cancer

Pancreatic cancer

Can you answer these questions?

More questions for: Amaryl, Pancreatic cancer

You may be interested in these reviews

More reviews for: Amaryl, Pancreatic cancer

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.